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ABSTRACT
xNAP1 (Xenopus nucleosome assembly protein)
belongs to the family of nucleosome assembly
proteins (NAPs) and shares 92% identity with
human and mouse NAP1. NAPs have been reported
to have a role in nucleosome assembly, cell cycle
regulation, cell proliferation and transcriptional
control, although the precise function of NAP1 is
still not clear. Here we report the identification of a
putative domain of xNAP1 by limited proteolysis.
This domain has been mapped in the xNAP1 protein
sequence to residues 38–282 and thus lacks the
acidic sequences at the N- and C-termini. We have
studied this domain and related fragments in vitro
and by a functional assay involving over-expression
of the protein in Xenopus laevis embryos. Analytical
ultracentrifugation shows that removal of the acidic
N- and C-terminal regions does not prevent the
formation of larger multimers, which are predomin-
antly hexadecamers. Injection of mRNA encoding
the full-length xNAP1 or the putative domain and
other related constructs into Xenopus embryos
gave identical phenotypes. These results are dis-
cussed in relation to protein–protein interactions
between NAP1 octamers and a possible ‘squelching’
mechanism.
INTRODUCTION
Xenopus nucleosome assembly protein (xNAP1) is a protein
of 392 residues and a molecular mass of 45258 Da, although
it migrates anomalously as  60 kDa species as assayed by
SDS–PAGE. xNAP1 is a member of a family of proteins
that share the ability to assemble histones into nucleosomes
on DNA in vitro. NAP1 proteins are universally present in
eukaryotic cells (1) and have homology with nucleosome
assembly proteins (NAPs), nucleoplasmin and N1/N2 in
the acidic C-terminus region (1). All these proteins possess
negatively charged regions, which have been suggested to
promote nucleosome assembly in vitro (2,3). xNAP1 is
closely related to human and mouse NAP1, sharing 92%
identity with these proteins.
Experiments on Drosophila NAP1 (4) revealed that
dNAP1 associates with H2A and H2B and that the protein
is found in the nucleus during S phase but is mainly cytoplas-
mic during G2 phase. NAP1 acts as a core histone shuttle,
delivering histones from the cytoplasm to the nucleus
where chromatin assembly takes place. Recent studies have
indicated a novel role for yNAP1 as a mediator of chromatin
ﬂuidity, by incorporating histone variants into chromatin and
assisting nucleosome sliding (5). In this model, NAP1 has a
much more active role in shaping chromatin structure.
Histone variants locally alter chromatin structure, with
histone chaperones and other cellular factors promoting
histone exchange and chromatin ﬂuidity (6). It is believed
that these processes can facilitate the interchange between
different chromatin states, having varying degrees of trans-
criptional activity (6).
Other studies have also linked NAPs with gene regulation.
NAP1 and NAP2 have been reported to form a complex with
p300 (7). Histone acetylation by p300 promotes the transfer
of H2A and H2B to NAP1 in vitro (8) potentially leading
to transcriptional activation mediated by disruption of the
histone octamer. In another study, xNAP1 was shown to
have a transcriptional role in embryonic blood formation.
xNAP1 is expressed tissue speciﬁcally in the ectoderm,
precisely overlying the ventral blood island and the outer
globin expressing cells (9). Depletion of xNAP1 in embryos
showed that mRNA levels of haematopoietic marker genes
SCL and AML decreased signiﬁcantly but endothelial
markers Hex and Fli-1 were unaffected. Since depletion of
xNAP1 led to gene-speciﬁc changes, it was proposed that
xNAP1 has a role in tissue restricted gene regulation (10).
There are a variety of conserved regions in NAP1
sequences. There are three negatively charged regions,
including a large acidic region at the C-terminal and a smaller
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the acidic C-terminal region is dispensable for nucleosome
assembly in vitro (11), but that it is required for the dissoci-
ation of H2A/H2B dimers from nuclear core particles,
whereby yNAP1 can subsequently facilitate nucleosome
sliding along the DNA to a thermodynamically favourable
position (5). dNAP1 has two PEST regions and a possible
PEST region has also been identiﬁed in xNAP1 (9). Nuclear
localization (NLS) and nuclear export signals (NES) also
appear to be conserved in NAPs (4,9,12,13). Studies by Li
et al. (12) identiﬁed a phosphorylation site adjacent to the
NLS sequence in dNAP1, and it has been suggested that
this plays a role in the translocation of NAP1 between the
cytoplasm and nucleus.
The yNAP1 NES sequence is necessary for shuttling the
protein from the nucleus to the cytoplasm. Failure to do so
was found to inhibit mitotic progression (13). The NES sequ-
ences have been shown to align in yeast, nematode, Xenopus,
Drosophila and human NAP1 (13). A KGIPEFWLT and a
SFFNFF sequence are also conserved in NAP1s across
these species (1,4,11). Although the KGIPEFWLT region has
been assigned no structural or functional role, the SFFNFF
sequence is necessary for nucleosome assembly (11).
Secondary structure analysis of the yeast orthologue,
yNAP1, by circular dichroism spectroscopy (14) indicates
that the C-terminal domain (approximately one-third of
the protein) is mostly unstructured with  25% a-helix con-
tent. Removal of residues 354–365 (PRAVDWFTGAALE)
located adjacent to the C-terminal acidic region caused a
substantial loss of a-helical structure. Recent studies
(15,16) suggest that NAP1 forms dimers, octamers and
hexadecamers in a concentration-dependent manner. Both
the dimer and the octamer of NAP1 appear to bind
histones H2A and H2B in a one NAP1 monomer per histone
monomer ratio, but the hexadecamer appears not to be
involved in histone interactions. Based on this, a model for
cell cycle-dependent shift of the NAP1 dimer–octamer equi-
librium has been proposed that reﬂects different biological
functions of NAP1 (16). According to this model, the low
concentrations of NAP1 in the nucleus at G1 lead to dimer
formation and a role in gene regulation via chromatin
rearrangement. Accumulation of NAP1 in the nucleus during
S phase leads to formation of octamers capable of carrying
multiple H2A.H2B dimers to replication sites.
In this article we deﬁne a structural domain of xNAP1 by
limited proteolysis. We show that this domain multimerizes,
forming predominantly hexadecameric complexes in vitro,
and that over-expression of the domain affects axial pattern-
ing in Xenopus, despite the lack of several of the conserved
regions believed to be important for activity.
MATERIALS AND METHODS
Cloning of expression constructs
Full-length and deletion constructs of xNAP1 were ampliﬁed
by PCR using Vent DNA polymerase (NEB) before cloning.
These NAP1 sequences were ligated into NcoI/XhoI restric-
ted pET28b(+) (Novagen) and XbaI/XhoI restricted pBUT
plasmids. Recombinants in each case were fully sequenced
to conﬁrm the presence of the insert.
Protein expression and purification
Expression of NAP1 and truncations thereof was carried out
in 500 ml 2xYT broth with 50 mgm l
 1 kanamycin antibiotic
inoculated with 10 ml of an overnight culture of Escherichia
coli BL21(DE3) pLysS. The culture was incubated at 37 C
by shaking until mid-log phase. Protein expression was
induced by 1 mM IPTG, and the cells incubated for a further
3 h before harvesting. The sample was lysed by sonication
(Vibracell  VCX 500 Jencons-PLS) and the soluble fraction
isolated by centrifugation. Recombinant protein was puriﬁed
using a Hi-trap chelating column (Amersham Pharmacia)
followed by preparative size exclusion chromatography on
a superose 12 column.
Limited proteolysis of xNAP1
NAP1 was subjected to limited proteolysis with either
chymotrypsin or trypsin (Sigma). The enzymes were dis-
solved in 1 mM HCl to make 5 mg ml
 1 stock solutions,
and aliquots were frozen at  20 C. The enzymes were
added to the xNAP1 (0.4 mg ml
 1) sample at an enzyme to
substrate (w/w) ratio of 1:10000 in a buffer of 100 mM
sodium phosphate at pH 7.0, 100 mM NaCl, 1 mM EDTA
and 1 mM DTT. The reactions were incubated at 25 C.
Aliquots were taken at various time points and the reaction
was stopped by the addition of PMSF (1 mM ﬁnal concen-
tration). Samples were analysed on 10% SDS–PAGE gels,
followed by staining with Coomassie blue.
Embryo manipulation
Embryos were obtained as described by Smith and Slack (17)
and staged according to Nieuwkoop and Faber (18). In vitro
transcription and microinjection of mRNA was carried out as
described previously (19,20). Injections of mRNA were
carried out at the 1-cell stage with 4 nl of RNA solution
(37 pg RNA total).
Mass spectroscopy
The digested xNAP1 samples were sent for mass spectro-
metry to M-Scan Ltd, Wokingham. Salts were removed
from the 1 ml sample by washing on a desalting column
with 0.1% aqueous formic acid, and the retained analytes
were eluted in a solvent of aqueous acetonitrile. The desalted
sample was loaded into a nanospray needle (MDS Protana)
and analysed using a Sciex Q-Star/Pulsar, ‘Q-TOF’ mass
spectrometer (MDS Sciex) operating in positive electrospray
mode. Data were collected by MCA acquisition and inter-
preted by manual inspection of the multiply charged species
observed in the spectrum.
Dynamic light scattering
Dynamic light scattering (DLS) was performed on puriﬁed
T2 protein at 20 C using a Protein Solutions DynaPro
temperature-controlled microsampler. The samples were in
gel ﬁltration buffer containing 10% glycerol and centrifuged
at 14 000 r.p.m. at 4 C for 10 min before DLS. From the
resulting hydrodynamic radius, Rh, an upper estimate of
the molecular mass, Mr, of the protein was obtained using
the empirical relationship for typical globular proteins:
Mr ¼ (1.68 · Rh)
2.34 using the supplied software.
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A Beckman Optima XL-A analytical ultracentrifuge
(Beckman-Coulter, Palo Alto, CA, USA) was used for sedi-
mentation equilibrium experiments. All measurements were
recorded at 20 C. T2 protein was puriﬁed by metal chelate
afﬁnity chromatography and size exclusion chromatography
on a Superdex 75 column, using the T2 buffer with an addi-
tional 10% glycerol. The protein was dialysed overnight into
AUC buffer (100 mM triethanolamine, 50 mM KCl, 1 mM
EDTA and 10% glycerol, pH 8.5). The experiment was
performed in six-channel cells of 12 mm optical path length,
using 90 ml of solution at three protein concentrations (0.14,
0.07 and 0.035 mg ml
 1). AUC buffer (100 ml) was loaded
into the corresponding channel. The rotor was accelerated
to 3000 r.p.m. and scans of absorbance versus radial displace-
ment were taken at 280 nm every 5 h for over 24 h and again
after a total of 48 h; equilibrium was seen to be reached after
20 h. Scans were analysed using the Beckman XL-A
software. However, the lower concentration samples could
not be ﬁtted with any degree of accuracy and were not
subsequently used.
RESULTS
xNAP1 contains structural domains resistant to
proteolytic digestion
Limited proteolysis is a sensitive technique that can be used
to examine the tertiary structure of proteins, since tightly fol-
ded domains are more resistant to proteolysis. We therefore
chose this approach to identify structural domains within
xNAP1. In separate experiments, xNAP1 was digested with
the proteases trypsin or a-chymotrypsin. Samples were
taken at various time intervals over a 2 h period. Trypsin
digestion (Figure 1a) produces a prominent fragment that
has an apparent molecular mass of  50 kDa (T1). Digestion
with a-chymotrypsin (Figure 1b) also reveals a prominent
fragment (C1) of  50 kDa; in both the cases the band corres-
ponding to the intact protein decreases in intensity. Digestion
with trypsin when extended over 24 h resulted in the appear-
ance of a major 35 kDa (T2) fragment (Figure 1c). In con-
trast, after a 24 h digestion of xNAP1 with a-chymotrypsin
the C1 fragment is still the predominant band, although two
faint additional bands,  35–37 kDa, in size are visible.
These faint bands are labelled C2 (i) and (ii) (Figure 1c).
After 24 h of digestion the samples were passed down a
nickel Hi-trap column (Amersham), and both the T2 and
C1 fragments were found in the ﬂow through. Since
the divalent ion chelating His-tag is at the N-terminus of
the puriﬁed recombinant xNAP1, and neither fragment is
capable of chelating nickel, the T2 and C1 fragments must
lack the N-terminus.
Proteolytic fragments C1 and T2 map to overlapping
regions of the xNAP1 sequence
We next determined the molecular mass of the xNAP1 putat-
ive structural domains T2 and C1 by mass spectroscopy.
Samples were digested with the respective enzymes under
limiting conditions and sent lyophilized for ESI mass spectro-
metry. The mass spectrometry results of the xNAP1 sample
digested with a-chymotrypsin showed that the largest frag-
ment observed is 39500 Da in size, while mass spectroscopy
of the trypsin digested sample detected three major fragments
between 27826 and 28970 Da. Since xNAP1 runs anoma-
lously on SDS–PAGE, we used 2D IEF to compare the pI
of both the T2 and C1 proteolytic fragments with that of
the full-length protein. T2 and C1 were found to have a pI
of  4.8 and  5.2, respectively, comparable with the full-
length xNAP1 pI of  5.2, and therefore both T2 and C1
can be expected also to run anomalously.
The T2 and C1 proteolytic fragments were also analysed
by N-terminal sequencing. The N-terminal sequence of C1
was identiﬁed as ALQERLDD and the N-terminal sequence
of the T2 fragment was identiﬁed as QLTAQM. These
N-termini are located only 13 amino acids apart in the
xNAP1 sequence. The C-termini of the fragments C1 and
T2 were predicted by determining the theoretical digestion
sites of trypsin and a-chymotrypsin in the xNAP1 sequence
in conjunction with the mass spectroscopy data. The C1
sequence was mapped onto a fragment of 342 amino acids
with a predicted mass of 39537 Da. The identiﬁcation of
the T2 N-terminal sequence, together with the known proteo-
lytic sites within the xNAP1 protein sequence, give predicted
molecular masses for three putative fragments: 27850
(239 amino acids), 28560 (245 amino acids) and 28973 Da
(249 amino acids). These masses are very similar to those
of the three major peaks obtained by mass spectroscopy
(27826, 28560 and 28970 Da). The 28560 Da fragment
ends closest to the NLS sequence, but not within it, and
was therefore chosen for further studies. The T2 and C1
structural domains are shown in Figure 2.
The T2 domain forms hexadecameric complexes in vitro
To facilitate analysis of the putative T2 domain the DNA
sequence encoding the T2 fragment was subcloned into the
pET-28b plasmid vector, allowing bacterial expression of
the domain as a histidine tagged fusion. The recombinant T2
protein was expressed and puriﬁed before being assayed by
analytical ultracentrifugation and dynamic light scattering
(DLS). DLS shows the presence of any polydispersity in the
sample and gives the hydrodynamic radius (Rh) of the com-
ponents. A major component (>90%) was observed with a
hydrodynamic radius of  9 nm (Figure 3), indicating that
the T2 domain forms discrete multimers. It is not possible to
calculate a true molecular weight from the Rh except for spher-
ical particles, as signiﬁcant asymmetry and/or unstructured
tails lead to an overestimate of the Mr. In addition, the histid-
ine tag, being unstructured and extended, will lead to a further
increase in Rh over and above that owing to asymmetry, and
hence would further overestimate the molecular weight.
We therefore performed sedimentation equilibrium on the
recombinant T2 domain in order to determine more precisely
the size of the protein complexes. The concentration distribu-
tion at equilibrium depends only on molecular mass, and
is independent of the shape of the molecule. Figure 4
shows the equilibrium distribution of the T2 sample at
0.14 mg ml
 1. When ﬁtted to a single species model, the
average molecular mass of the sample was 430 kDa
(± 60 kDa). The T2 fragment has a molecular mass of
28560 Da but the recombinant form used in this experiment
Nucleic Acids Research, 2006, Vol. 34, No. 17 4895also includes a 2470 Da his-tag sequence, giving a total mole-
cular weight of 31030 Da. Thus AUC suggests that the
T2 domain forms oligomeric complexes of 12–16 subunits,
indicating a predominance of hexadecamers. The data could
also be ﬁtted to an octamer–hexadecamer equilibrium
model, and Kd values in the range 0.3–2.0 mM gave models
that described the data equally well.
Expression of full-length xNAP1, C1 or T2 domains
in Xenopus laevis embryos leads to identical
phenotypic defects
NAP1 has a role in chromatin ﬂuidity that could affect trans-
cription and hence embryonic development. Several studies
have shown that NAP1 has an important role in development.
Inactivation of NAP1 in Drosophila is embryonic lethal (21)
and in Xenopus, has also been shown to have a role in tissue
speciﬁc gene regulation (9,10). xNAP1 has a number of
conserved regions, which may be important in these func-
tions, but several of these are missing in the structural domain
T2. In particular, the T2 domain lacks the C-terminal acidic
regions and hence the PEST sequence. We, therefore, tested
how these truncations affected the in vivo activity of xNAP1.
To test the in vivo activity of the structural domains C1 and
T2 we used gain of function analysis by expressing these
domains in Xenopus embryos. Injection of in vitro transcribed
mRNA encoding the protein of interest into Xenopus is a
well-established developmental investigative tool, since
over-expression of the target protein can lead to clues to its
function in vivo. We subcloned the DNA encoding the T2
fragment into the pBUT-2 plasmid, which provides the
50-UTR (50-untranslated region) and 30-UTRs of the globin
gene that both stabilizes the mRNA post-injection and
maximizes its translation, therefore increasing the levels of
encoded protein. We also subcloned two extra constructs
(Figure 5a), one based on the proteolytic fragment T2 but
Figure 1. Limited proteolysis of xNAP1 with trypsin and a-chymotrypsin xNAP1 (0.4 mg ml
 1) was digested with either trypsin (a)o ra-chymotrypsin (b)a t
a w/w ratio of 1:10 000 enzyme to substrate. The reaction was incubated at 25 C and stopped with 1 mM PMSF and assayed by SDS–PAGE. The most distinct
fragment visible after a 2 h digestion by trypsin is  50 kDa (T1). A 50 kDa fragment is also visible after 2 h digestion with a-chymotrypsin (C1). (c) Further
digestion for a period of 24 h with trypsin and with a-chymotrypsin reveals a fragment of  35 kDa in the trypsin lane (T2). A 24 h digestion with
a-chymotrypsin still shows a strong fragment corresponding to C1. Two smaller fragments  35–37 kDa in size are labelled C2 (i) and (ii).
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based on the full-length xNAP1 lacking only the PEST
sequence. These proteins were exogenously expressed in
Xenopus embryos and assayed for any phenotypic changes
thereby induced.
The mRNA coding for either xNAP1 or its domains was
injected into 1-cell embryos, and these were cultured until
stage 36 when phenotypes were observed. Similar phenotypes
were observed in stage 36 embryos regardless of whether
xNAP1 or truncated xNAP1 mRNA was injected. The
affected embryos showed shortening of the embryo along
the anterior/posterior axis, microcephaly and reduced mobil-
ity (Figure 5b). The proportion of embryos that displayed
these effects with 100 pg of injected mRNA varied between
27 and 55% depending on the expressed protein (Table 1).
Western blotting showed equal levels of expression of the
proteins (data not shown). Uninjected and b-gal mRNA injec-
ted control embryos were unaffected.
In previous experiments, we have shown that antisense
morpholino-injected NAP knockout embryos are also par-
tially paralysed (10) and, at high morpholino concentrations,
have truncated axes (A. Abu-daya and M. J. Guille, unpub-
lished data), correlating with the phenotypes observed here.
The fact that gene knockout and over-expression experiments
lead to similar phenotypes suggests a ‘squelching’ mechan-
ism, as discussed below.
DISCUSSION
Here, we report the identiﬁcation of a structural domain of
xNAP1 that retains a functional activity. Digestion of full-
length xNAP1 with trypsin or a-chymotrypsin gives rise to
two fragments (T1 and C1 respectively). Increased enzyme
concentration or longer digestion times with trypsin gener-
ated a smaller fragment with an apparent molecular weight
of 35 kDa (T2) as assayed by SDS–PAGE, whereas the
fragment arising from a-chymotrypsin digestion is largely
unaltered by longer digestion times. Therefore, the T2 frag-
ment is likely to represent the smallest stable proteolytic
domain of xNAP1, and it is located almost entirely within
the larger C1 fragment.
N-terminal sequencing of T2 and C1 successfully deﬁned
the N-termini of both the T2 (QLTAQM) and C1 (AALQER)
fragments. The N-termini of these two fragments are separ-
ated by only 13 amino acids. The T2 N-terminus is nearer
to the predicted wild-type start methionine, with no available
trypsin site between the T2 and C1 N-termini. However,
overall the T2 fragment was the smaller of the two regions,
lacking the C-terminal acidic region whereas the C1 fragment
extends to the end of the xNAP1 sequence. The truncation of
the C-terminus in the T2 fragment leads to the loss of the
Figure 2. xNAP1 amino acid sequence showing T2 and C1 N-terminal
sequences. The N-terminus of the trypsin fragment T2 (red box) and the
N-terminus of chymotrypsin fragments C1 (green box) are 13 amino acids
apart. The predicted C-terminus of T2 and C1 are also shown (red and green,
respectively). Acidic regions are underlined and the bipartite nuclear
localization signal is shown in blue. Preceding the wild-type start methionine
(numbered 1) is the His-tag sequence present in the recombinant T2 protein.
Figure 3. Dynamic light scattering of the T2 domain T2 was purified by
metal chelate affinity and size exclusion chromatography. Buffers contained
10% glycerol. The T2 protein sample (0.15 mg ml
 1) has one major
component, comprising 93.6% (w/w) of the protein with a hydrodynamic
radius of 9.6 nm.
Figure 4. Sedimentation equilibrium of the T2 domain. The sedimentation
equilibrium profile of T2 (at 0.14 mg ml
 1) in 10% glycerol is shown. The
experiment was performed using an Optima  XLA at 3000 r.p.m., 20 C and
the scans taken at 280 nm every 5 h over 24 h. The fitted curve is for a single-
species model with Mr ¼ 430 kDa.
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proposed to have functional roles. Both T2 and C1 fragments
contain the NES and the full bi-partite NLS of the complete
protein, as well as the conserved KGIPEFWLT sequence.
Full-length NAP1 monomers readily multimerize into
complexes varying in size from dimers to octamers and
hexadecamers, in a concentration-dependent manner (16).
The trypsin fragment T2 retains the ability to multimerize
as assayed by dynamic light scattering and sedimentation
equilibrium, forming predominantly hexadecameric com-
plexes. It has been proposed that the NAP1 octamers form
annular discs, with two discs stacking face to face to form
hexadecamers (16). If the negatively charged acidic regions
in the wild-type protein were near the octamer–octamer inter-
face, their absence in the T2 domain could favour the hexa-
decamer by reducing charge repulsion between octamers.
Since these experiments were completed, the ﬁrst crystal
structure of NAP1 (from yeast) has become available (22).
The protein crystallizes as a dimer, the dimer interface
being maintained by two a-helices in the N-terminal domain
of the protein. The remainder of the protein is formed from a
core of two further helices (a3 and a4) and six b strands, plus
a C-terminal domain consisting of three helices (a6–a8). If
the structure of yeast and Xenopus NAP1s are similar, as
seems likely from their conserved sequences, then we can
locate the proteolytic sites for xNAP1 with reference to the
structure of yNAP1 when the sequences are aligned.
The N-terminus of the chymotryptic (C1) fragment, Ala51
in xNAP1, corresponds to the start of the ﬁrst a helix (Q38
in yNAP1), and thus to the ﬁrst structural domain. The
N-terminus of the T2 tryptic fragment (Gln38) is 13 amino
acid residues away from this in the unstructured region, but
is the nearest basic amino acid to the C1 site. The C-terminus
of the T2 fragment (Gly282) corresponds to Lys298 in
yNAP1, and lies within the loop between b5 and b6, which
is disordered in the crystal structure and hence readily sus-
ceptible to proteolysis. Thus, it is clear that the T2 domain
of xNAP1 is lacking b6 plus the three C-terminal helices,
a6, a7 and a8. Our data suggest that these structural
elements are not required for the formation of octamers and
hexadecamers.
Considerable evidence now suggests that NAP1 proteins
have a role in developmental regulation by controlling tran-
scriptional activity, most likely at the level of chromatin
assembly (10,23). We tested the ability of the putative
domains C1 (51–392) and T2 (38–282) to affect development
relative to the full-length xNAP1 by exogenous expression of
these constructs. In addition to the full-length xNAP1 and the
putative domains mapped by partial proteolysis, two other
constructs were created for expression in Xenopus embryos.
These consisted of the T2 fragment minus the C-terminal
half of the bi-partite NLS (38–260), and a construct lacking
much of the C-terminus up to and including the PEST
sequence (1–336).
Over-expression of all these constructs led to very similar
axial patterning defects that are consistent with interference
of NAP function. A ‘squelching’ model could provide a
possible explanation of our observations. In this model,
over-expression of exogenous NAP1 protein leads to a
Figure 5. Injection of any of the xNAP1 constructs leads to axial defects. (a) Injected constructs are shown with conserved regions indicated. Basic regions
marked by a black box, the PEST sequence is shown in green embedded in the C-terminal basic region. The NLS is marked in red and the SFFNFF shown in
purple. (b) One-cell embryos were injected with 100 pg of either full-length or truncated versions of xNAP1. Un-injected embryos from the same fertilization
were cultured in parallel as controls. Embryos were grown in modified bath serum at 18 C until stage 36, fixed in MEMFA (0.5 M MOPS, pH 7.4, 0.5 M EGTA,
0.5 M MgSO4 and 37% formaldehyde) and stored at  20 C in methanol before photographing. All forms of injected xNAP1 gave rise to a shorter A/P axis (lack
of head and tail are arrowed) than the un-injected control embryos shown in (c).
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tion of hexadecameric NAP1 complexes that have previously
been shown to be unable to bind histones (16). We have
shown that the T2 domain retains the ability to multimerize
in vitro. Indeed, the predominance of the hexadecameric
form of truncated NAP1 suggests that this complex may be
favoured by removal of the acidic tails. Presumably, trun-
cated NAP1 can form mixed hexadecameric complexes
with wild-type NAP1, thus transferring endogenous NAP1
into inactive complexes.
Our in vitro studies show that the ability to multi-
merizeresidesinthecentralregionofthefull-lengthNAP1pro-
tein, and removal of the acidic N- and C-terminal regions
may indeed favour formation of larger multimers. In vivo
injection of a range of truncated xNAP1 constructs into
Xenopus embryos leads to axial defects. The ability to
produce this phenotype resides primarily in the central
51–260 amino acid sequence and may reﬂect the ability of this
regiontomultimerizeintoanon-histonebindinghexadecamer.
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